Eton 2026 meeting backs board and auditor
Eton Pharmaceuticals, Inc. held its 2026 Annual Meeting of Stockholders virtually on June 9, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Eton Pharmaceuticals, Inc. held its 2026 Annual Meeting of Stockholders virtually on June 9, 2026. Stockholders elected Jenn Adams and Charles J. Casamento to the board for three-year terms and ratified Grant Thornton LLP as independent registered public accounting firm for the year ending December 31, 2026.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes for Jenn Adams: 13,370,948 votes
Votes withheld Jenn Adams: 2,149,317 votes
Votes for Charles J. Casamento: 9,925,548 votes
+5 more
8 metrics
Votes for Jenn Adams
13,370,948 votes
Election of director at 2026 Annual Meeting
Votes withheld Jenn Adams
2,149,317 votes
Election of director at 2026 Annual Meeting
Votes for Charles J. Casamento
9,925,548 votes
Election of director at 2026 Annual Meeting
Votes withheld Charles J. Casamento
5,594,717 votes
Election of director at 2026 Annual Meeting
Broker non-votes (directors)
4,664,035 votes
Both director election proposals
Votes for auditor ratification
16,942,328 votes
Ratification of Grant Thornton LLP for 2026
Votes against auditor ratification
3,236,671 votes
Ratification of Grant Thornton LLP for 2026
Abstain on auditor ratification
5,301 votes
Ratification of Grant Thornton LLP for 2026
Key Terms
broker non-votes, independent registered public accounting firm, Annual Meeting of Stockholders, emerging growth company
4 terms
broker non-votes financial
"Nominee | For | Withheld | Broker Non-Votes Jenn Adams | 13,370,948 | 2,149,317 | 4,664,035"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"ratified the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
Annual Meeting of Stockholders financial
"The 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of Eton Pharmaceuticals, Inc. was held virtually on June 9, 2026"
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ETON stockholders approve at the 2026 annual meeting?
ETON stockholders elected Jenn Adams and Charles J. Casamento to three-year board terms and ratified Grant Thornton LLP as independent auditor for the year ending December 31, 2026. Both proposals received majority support from votes cast at the virtual meeting.
How did ETON stockholders vote on director Jenn Adams?
Jenn Adams received 13,370,948 votes for election and 2,149,317 votes withheld, with 4,664,035 broker non-votes. This indicates strong support from voting stockholders for her continued service as a director on Eton Pharmaceuticals’ board.
What were the voting results for director Charles J. Casamento at ETON?
Charles J. Casamento received 9,925,548 votes for election and 5,594,717 votes withheld, plus 4,664,035 broker non-votes. While he faced more withheld votes than Jenn Adams, the support remained sufficient for election to a three-year board term.
Did ETON stockholders ratify Grant Thornton LLP as auditor for 2026?
Yes. Stockholders cast 16,942,328 votes for ratifying Grant Thornton LLP as Eton Pharmaceuticals’ independent registered public accounting firm for 2026, with 3,236,671 votes against and 5,301 abstentions, confirming continued engagement of the same external audit firm.
When and how was ETON’s 2026 annual meeting held?
Eton Pharmaceuticals held its 2026 Annual Meeting of Stockholders virtually on June 9, 2026. Stockholders participated remotely to vote on the election of two directors and the ratification of Grant Thornton LLP as the company’s independent registered public accounting firm.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates